Get notified of page updates

Cancer Risk

Read about different genes that are linked to hereditary cancer, their associated risks and guidelines for screening, preventing and treating cancers in people with inherited mutations in these genes.

Stay up to date on research and information

Sign Up for FORCE Newsletters
Glossary on
off

Cancer risk associated with inherited  mutations

If you have tested positive for an inherited mutation, we recommend that you speak with a genetics expert who can look at your personal and family history of cancer and can help you decide on a plan for managing your cancer risk. Note that when we use "men" and "women" we are referring to the sex you were assigned at birth.

Breast cancer risk in women

Women who have a gene mutation have an increased risk of developing a specific type of breast cancer called lobular breast cancer. The estimated lifetime risk in a woman with a mutation is 40-60 percent. 

Risks for all people

Gastric cancer: People with an inherited mutation have an increased risk of developing a specific type of stomach (gastric) cancer called diffuse gastric cancer. 

  • lifetime risk for gastric cancer is 67 percent for men and 83 percent for women. This compares to less than 1 percent in the general population.
  • average age of diagnosis is 37 compared to 68 in the general population. 

Some research has suggested that mutations may increase the risk for other cancers. However, these studies are not conclusive and lifetime risks for these cancers are not clear. For this reason, genetics experts often look at family history of cancer to help people with mutations understand their risk for additional cancers. Research on and other cancer risk is ongoing.

Graph of lifetime risk for stomach cancer in women with a <button
                x-data
                class='glossary-tip tt-cdh1'
                x-tooltip='<p>CDH1 is the name of a gene that has been&nbsp;associated with hereditary diffuse gastric cancer syndrome. Mutations in CDH1 increase&nbsp;the risk of stomach cancer and breast cancer in women. CDH1 stands for "Cadherin-1."</p>
'
            >CDH1</button> mutation     Graph of lifetime risk of stomach cancer in man with a <button
                x-data
                class='glossary-tip tt-cdh1'
                x-tooltip='<p>CDH1 is the name of a gene that has been&nbsp;associated with hereditary diffuse gastric cancer syndrome. Mutations in CDH1 increase&nbsp;the risk of stomach cancer and breast cancer in women. CDH1 stands for "Cadherin-1."</p>
'
            >CDH1</button> mutation

Graph of lifetime risk for breast cancer in woman with a <button
                x-data
                class='glossary-tip tt-cdh1'
                x-tooltip='<p>CDH1 is the name of a gene that has been&nbsp;associated with hereditary diffuse gastric cancer syndrome. Mutations in CDH1 increase&nbsp;the risk of stomach cancer and breast cancer in women. CDH1 stands for "Cadherin-1."</p>
'
            >CDH1</button> mutation

It is important to note that cancer risks are estimates over the course of a person's lifetime. Your lifetime risk and risk over the next five years will vary depending on:

  • current age
  • sex assigned at birth
  • specific mutation
  • personal and family health history
  • diet, exercise, lifestyle and other factors

Get Support
Get Support

FORCE offers many peer support programs for people with inherited mutations. 

Open Clinical Trials
Open Clinical Trials

NCT02665195: Registry Of MultiPlex Testing (PROMPT). PROMPT is an online research registry. The goal of PROMPT is to help researchers to better understand the risks that are linked to mutations in less well-studied genes. People with inherited mutations can enroll in PROMPT to help researchers learn more about cancer risks. 

Open Clinical Trials
Open Clinical Trials

Last updated December 30, 2023